Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Flagship's Lila adds $115M to series A, bringing total to $350M
The expansion includes funds from the venture arm of AI titan Nvidia and brings the company's total fundraising to more than half a billion dollars.
Darren Incorvaia
Oct 14, 2025 11:33am
Sponsored
Understanding the Impact of PFAS "Forever Chemicals" on Medical Devices
Oct 13, 2025 8:00am
Takeda turns to AI drug designer after whittling down R&D focus
Oct 14, 2025 5:00am
Sponsored
Neuroinflammation a Key Underlying Factor in Alzheimer’s Disease Risk
Oct 13, 2025 8:00am
Kailera raises hefty $600M to take Zepbound rival into ph. 3
Oct 14, 2025 9:20am
J&J reveals plan to spin off its $9B orthopedics business
Oct 14, 2025 11:30am
More News
Fierce Biotech Fundraising Tracker: Lila, Kailera & more
Oct 14, 2025 11:30am
Roche nabs FDA clearance for Alzheimer’s biomarker blood test
Oct 14, 2025 11:12am
BioCryst inks $700M Astria deal to rival Takeda in rare disease
Oct 14, 2025 10:30am
Fierce Pharma
Halozyme CEO targets new deals as IRA uncertainty subsides
Oct 14, 2025 9:40am
See more stories
